Trial: 202104163

A phase I/II study of copanlisib plus venetoclax for the treatment of relapsed/refractory diffuse large B-cell lymphoma

Phase

I/II

Principal Investigator

Bartlett, Nancy

Disease Site

Non-Hodgkin Lymphoma

Learn more about this study at: clinicaltrials.gov